In our study, the results of in vitro and in vivo experiments elucidate on SERT-targeted therapy of colon cancer, showing a novel feedback mechanism by which cancer cells maintain the homeostasis of intracellular serotonin, and suggesting a novel SSRIs-based strategy for colon cancer treatment. Here, SLC6A4 is linked to malignant colon neoplasm.